[go: up one dir, main page]

MA46239A - Mousse pharmaceutique stable - Google Patents

Mousse pharmaceutique stable

Info

Publication number
MA46239A
MA46239A MA046239A MA46239A MA46239A MA 46239 A MA46239 A MA 46239A MA 046239 A MA046239 A MA 046239A MA 46239 A MA46239 A MA 46239A MA 46239 A MA46239 A MA 46239A
Authority
MA
Morocco
Prior art keywords
stable pharmaceutical
pharmaceutical foam
foam
stable
pharmaceutical
Prior art date
Application number
MA046239A
Other languages
English (en)
Inventor
Tamar Auerbach-Nevo
Ashley Deanglis
Israel Nur
Original Assignee
Ethicon Inc
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL247810A external-priority patent/IL247810A0/en
Application filed by Ethicon Inc, Omrix Biopharmaceuticals Ltd filed Critical Ethicon Inc
Publication of MA46239A publication Critical patent/MA46239A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MA046239A 2016-09-14 2017-09-11 Mousse pharmaceutique stable MA46239A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662394371P 2016-09-14 2016-09-14
IL247810A IL247810A0 (en) 2016-09-14 2016-09-14 Stable pharmaceutical foam

Publications (1)

Publication Number Publication Date
MA46239A true MA46239A (fr) 2019-07-24

Family

ID=60022140

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046239A MA46239A (fr) 2016-09-14 2017-09-11 Mousse pharmaceutique stable

Country Status (9)

Country Link
EP (1) EP3512502A1 (fr)
JP (1) JP7114597B2 (fr)
KR (1) KR102656742B1 (fr)
CN (1) CN109789091A (fr)
AU (1) AU2017328480A1 (fr)
CA (1) CA3036770A1 (fr)
IL (1) IL265252B2 (fr)
MA (1) MA46239A (fr)
WO (1) WO2018051325A1 (fr)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2492458A (en) 1944-12-08 1949-12-27 Jr Edgar A Bering Fibrin foam
CH264752A (de) * 1947-06-03 1949-10-31 Hoffmann La Roche Verfahren zur Herstellung von Trägern für Arzneimittel.
JPS5814813B2 (ja) * 1976-11-09 1983-03-22 味の素株式会社 起泡剤及びその製造法
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
AU7004900A (en) 1999-07-21 2001-02-05 Imedex Biomateriaux Adhesive protein foam for surgical and/or therapeutic uses
DE60101956T2 (de) 2000-02-25 2004-12-23 Sierra, David, Aptos Schaumbildender wundverband
DE50207201D1 (de) 2001-03-26 2006-07-27 Bayer Materialscience Ag Polycarbonat mit ausgeprägtem scherentzähungsverhalten
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US6749842B2 (en) * 2002-01-24 2004-06-15 Midwest Grain Products Liquid foam builder containing hydrolyzed grain protein
WO2009023745A1 (fr) 2007-08-14 2009-02-19 The Regents Of The University Of California Mousses mésocellulaires oxydes utilisées comme compositions hémostatiques et procédés d'utilisation
WO2009083544A2 (fr) * 2007-12-28 2009-07-09 Kuros Biosurgery Ag Protéines hybrides du pdgf incorporées dans des mousses de fibrine
RU2545810C2 (ru) * 2008-02-29 2015-04-10 Ферросан Медикал Дивайсиз А/С Устройство для ускорения остановки кровотечения и/или заживления ран
WO2009109963A1 (fr) * 2008-03-03 2009-09-11 Omrix Biopharmaceuticals Ltd. Éponge de gélatine comprenant un principe actif, sa préparation et son utilisation
US8512740B2 (en) 2008-03-26 2013-08-20 Baxter International Inc. Fibrin foam and process for making
US8753670B2 (en) 2008-03-26 2014-06-17 Baxter International Inc. Fibrin foam and process
US20110036133A1 (en) * 2008-04-18 2011-02-17 N. V. Organon Purification of protein hydrolysate and the result and products
US20100021527A1 (en) 2008-07-25 2010-01-28 Chunlin Yang Collagen-related peptides and uses thereof and hemostatic foam substrates
US8778883B2 (en) 2009-11-13 2014-07-15 Industrial Technology Research Institute Foamy biomaterial for biological tissue repair
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
US8680240B1 (en) 2012-11-01 2014-03-25 George David Falus Tissue sealant for use in non-compressible hemorrhage
JP2016501255A (ja) 2012-12-07 2016-01-18 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血フォーム
CN105543315A (zh) * 2015-12-16 2016-05-04 陕西科技大学 胶原蛋白类发泡剂、其复配改性发泡剂以及二者的制备方法

Also Published As

Publication number Publication date
IL265252A (en) 2019-05-30
CA3036770A1 (fr) 2018-03-22
WO2018051325A1 (fr) 2018-03-22
JP7114597B2 (ja) 2022-08-08
CN109789091A (zh) 2019-05-21
IL265252B2 (en) 2023-11-01
KR20190054110A (ko) 2019-05-21
JP2019526646A (ja) 2019-09-19
KR102656742B1 (ko) 2024-04-15
AU2017328480A1 (en) 2019-03-14
EP3512502A1 (fr) 2019-07-24
IL265252B1 (en) 2023-07-01

Similar Documents

Publication Publication Date Title
EP3493799A4 (fr) Composition pharmaceutique decannabis
DK3479819T5 (da) Stabilt væskeformigt farmaceutisk præparat
SI4070787T1 (sl) Farmacevtske formulacije
HUE054344T2 (hu) Gyógyászati készítmények AZD9291 tartalommal
EP3493798A4 (fr) Composition pharmaceutique decannabis
EP3454899C0 (fr) Composition pharmaceutique
MA43705A (fr) Formulation pharmaceutique
MA42303A (fr) Formulations pharmaceutiques
DK3634377T3 (da) Farmaceutisk formulering
EP3603642A4 (fr) Préparation pharmaceutique
DK3463345T3 (da) Farmaceutiske kombinationer
MA43375A (fr) Mousse minérale ultra-légère
EP3437644A4 (fr) Médicament
MA44987A (fr) Formulations de médicaments améliorées
MA47516A (fr) Composition pharmaceutique
EP3383371A4 (fr) Formulation pharmaceutique
EP3402470A4 (fr) Composition pharmaceutique stable
EP3646866A4 (fr) Préparation pharmaceutique
DK3280447T3 (da) Farmaceutiske formuleringer
EP3527216A4 (fr) Médicament
EP3337463A4 (fr) Formulations pharmaceutiques
HUE053974T2 (hu) Szemészeti gyógyászati készítmény
HUE069648T2 (hu) Gyógyszerészeti készítmény
EP3646863A4 (fr) Composition pharmaceutique
EP3498467C0 (fr) Produit en mousse